C07C 59/255
Tartaric acid
C07C59/255 (Tartaric acid) appears on 196 US grants and 285 published applications in this corpus.
Search patents in C07C- Granted patents
- 196
- Published applications
- 285
- Assignees
- 190
- Inventors
- 903
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 4 |
| 2005 | 0 | 1 |
| 2006 | 1 | 8 |
| 2007 | 2 | 3 |
| 2008 | 1 | 4 |
| 2009 | 4 | 4 |
| 2010 | 5 | 11 |
| 2011 | 6 | 8 |
| 2012 | 2 | 3 |
| 2013 | 4 | 14 |
| 2014 | 7 | 13 |
| 2015 | 9 | 12 |
| 2016 | 11 | 18 |
| 2017 | 14 | 8 |
| 2018 | 9 | 9 |
| 2019 | 11 | 13 |
| 2020 | 9 | 11 |
| 2021 | 5 | 15 |
| 2022 | 8 | 16 |
| 2023 | 11 | 30 |
| 2024 | 12 | 32 |
| 2025 | 14 | 29 |
| 2026 | 9 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for the preparation of cysteamine bitartrate and product so obtained29 Sep 2026US 12,747,204 B2Recordati Industria Chimica e Farmaceutica S.p.A.
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Pharmaceutical salt of an arylpyrrole derivative26 May 2026US 12,637,424 B2Sentinel Oncology Limited
- Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof26 May 2026US 12,637,470 B2Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
- Salt and crystal forms of 4-amino-5-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-z-yl)thieno[2.3-b]pyridin-6(7H)-one12 May 2026US 12,624,049 B2University Health Network
- Salt and crystal form of anti-tumor heterocyclic compound8 Oct 2026US 2026/0308143 A1Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Pharmaceutically acceptable salt and crystal form of 1,4-dihydro-1,6-naphthyridine amide compound and preparation method therefor10 Sep 2026US 2026/0265249 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Psilocybin analogs, salts, compositions, and methods of use27 Aug 2026US 2026/0250246 A1Cybin IRL Limited
- Crystal form of alk inhibitor or salt and solvate thereof, preparation method therefor, and use thereof30 Jul 2026US 2026/0217692 A1
- Lsd salt crystal forms23 Jul 2026US 2026/0209229 A1Definium Therapeutics US, Inc.
Most cited
By later US patents
- Crystalline forms of a purine derivative99US 8,889,861 B2Cyclacel Limited · 2014
- Toll like receptor modulator compounds60US 9,670,205 B2Gilead Sciences, Inc. · 2017
- Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases47US 8,921,393 B2ACADIA Pharmaceuticals Inc. · 2014
- Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases46US 7,601,740 B2ACADIA Pharmaceuticals Inc. · 2009
- Methods and compositions for treating inflammation or arthritis45US 4,680,309 ANational Research Laboratories · 1987